Isolation of a Novel Thioflavin S–Derived Compound That Inhibits

Total Page:16

File Type:pdf, Size:1020Kb

Isolation of a Novel Thioflavin S–Derived Compound That Inhibits Published OnlineFirst September 18, 2013; DOI: 10.1158/1535-7163.MCT-13-0142 Molecular Cancer Small Molecule Therapeutics Therapeutics Isolation of a Novel Thioflavin S–Derived Compound That Inhibits BAG-1–Mediated Protein Interactions and Targets BRAF Inhibitor–Resistant Cell Lines Marion Enthammer1, Emmanouil S. Papadakis3, Maria Salome Gachet2, Martin Deutsch1, Stefan Schwaiger2, Katarzyna Koziel1, Muhammad Imtiaz Ashraf1, Sana Khalid1, Gerhard Wolber2, Graham Packham3, Ramsey I. Cutress3, Hermann Stuppner2, and Jakob Troppmair1 Abstract Protein–protein interactions mediated through the C-terminal Bcl-2–associated athanogene (BAG) domain of BAG-1 are critical for cell survival and proliferation. Thioflavin S (NSC71948)—a mixture of compounds resulting from the methylation and sulfonation of primulin base—has been shown to dose- dependently inhibit the interaction between BAG-1 and Hsc70 in vitro. In human breast cancer cell lines, with high BAG-1 expression levels, Thioflavin S reduces the binding of BAG-1 to Hsc70, Hsp70, or CRAF and decreases proliferation and viability. Here, we report the development of a protocol for the purification and isolation of biologically active constituents of Thioflavin S and the characterization of the novel compound Thio-2. Thio-2 blocked the growth of several transformed cell lines, but had much weaker effects on untransformed cells. Thio-2 also inhibited the proliferation of melanoma cell lines that had become resistant to treatment with PLX4032, an inhibitor of mutant BRAF. In transformed cells, Thio-2 interfered with intracellular signaling at the level of RAF, but had no effect on the activation of AKT. Thio-2 decreased binding of BAG-1 to Hsc70 and to a lesser extent BRAF in vitro and in vivo, suggesting a possible mechanism of action. Given that tumors frequently develop resistance to kinase inhibitors during treatment, Thio-2 and related compounds may offer promising alternative strategies to currently available therapies. Mol Cancer Ther; 12(11); 2400–14. Ó2013 AACR. Introduction ylation and requires the assembly of signalosomes, which, RAF kinases are part of an evolutionarily conserved along with the core components of the signaling cascade, core-signaling cascade downstream of activated receptor contain accessory molecules required for modulation, tyrosine kinases and the small G-protein RAS (1). The compartmentalization, and specificity (1–3). RAF kinases three RAF isoforms, ARAF, BRAF, and CRAF (also RAF-1), are upstream of a three-tiered mitogen–activated protein are involved in mitogen, survival, and differentiation kinase (MAPK) cascade comprising the dual-specificity signaling. Their activation is a complex process involving Ser/Thr MAPK kinases (MAP2K) MEK1/2 and their interactions with proteins and lipids as well as phosphor- substrates ERK1/2, which are required for most reported RAF effects (4, 5). Several proteins have been described, which may be important for RAF activation and signaling under specific 1 Authors' Affiliations: Daniel Swarovski Research Laboratory, Depart- conditions at distinct cellular sites. These include the Bcl- ment of Visceral, Transplant and Thoracic Surgery, Innsbruck Medical University; 2Institute of Pharmacy/Pharmacognosy, Center of Molecular 2–associated athanogene 1 (BAG-1; refs. 6–10). BAG-1 was Biosciences, University of Innsbruck, Innsbruck, Austria; and 3Cancer originally identified as a Bcl-2–interacting protein with Research UK Centre, Cancer Sciences Division, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, United antiapoptotic activity (11). BAG-1 is a member of a family Kingdom of proteins characterized by at least one copy of an Note: Supplementary data for this article are available at Molecular Cancer approximately 100 amino acid–long evolutionarily con- Therapeutics Online (http://mct.aacrjournals.org/). served a-helical BAG domain that allows them to interact with and regulate the Hsp70 family of molecular chaper- Current address for G. Wolber: Freie Universitat€ Berlin, Institute of Phar- macy, Department Pharmaceutical and Medicinal Chemistry, Berlin, ones (12, 13). BAG-1 can bind to the kinase domain of Germany. CRAF (14) or BRAF (15), and in vitro experiments showed Corresponding Author: Jakob Troppmair, Innsbruck Medical University, that BAG-1/CRAF interaction leads to the activation of Innrain 66, Innsbruck 6020, Austria. Phone: 43-512-504-27819; Fax: 43- CRAF independently of RAS (14). RAS-independent RAF 512-504-24624; E-mail: [email protected] activation, which results in the activation of ERK1/2, is also doi: 10.1158/1535-7163.MCT-13-0142 observed in cells overexpressing BAG-1 (16). ERK1/2 acti- Ó2013 American Association for Cancer Research. vation can be terminated by stress-induced upregulation 2400 Mol Cancer Ther; 12(11) November 2013 Downloaded from mct.aacrjournals.org on September 25, 2021. © 2013 American Association for Cancer Research. Published OnlineFirst September 18, 2013; DOI: 10.1158/1535-7163.MCT-13-0142 Thio-2 Inhibitor of BAG-1–Mediated Protein Interactions of Hsp70 (16). Mechanistically, this may be explained by (42). Thioflavin S also reduces viability of wild-type (wt) the competition between CRAF and Hsp70 for a common but not BAG-1–deficient mouse embryonic fibroblasts binding site in helix 2 of the BAG domain. Genetic dis- (42). Until now, hit-to-lead development of drug-like ruption of BAG-1 in mice has no effect on the activation of inhibitors has been precluded by complexity of the Thio- ERK1/2 by mitogens (15). Nevertheless, subcellular local- flavin S mixture. Here, we report the isolation and puri- ization studies have suggested that BAG-1 forms a mito- fication of the compounds Thio-2, Thio-3, Thio-5, and chondrial survival signaling complex with Hsp70/AKT Thio-6 from Thioflavin S and their structural characteri- and BRAF, the absence of which may account for zation. We also demonstrate the ability of Thio-2 to block increased apoptosis in the liver and developing nervous signal propagation via the MAPK pathway, to impede the system of BAG-1–deficient mouse embryos (15). Evidence proliferation of RAF-transformed cells, and inhibit the for BAG-1 involvement in RAF-driven transformation has interaction of BAG-1 with Hsc70 and to a lesser degree been provided by the demonstration that BAG-1 hetero- RAF in HEK293 cells. zygosity in mice expressing a constitutively active form of CRAF in type II pneumocytes significantly reduces onco- gene-induced lung adenoma growth (17). In this model, Materials and Methods RAF-downstream signaling was unaffected, whereas Reagents reduced BAG-1 expression specifically targeted tumor General chemicals were of molecular biology grade and cells to apoptosis (17). were purchased either from Sigma-Aldrich or Fisher Activating mutations in RAF kinases are almost exclu- Scientific, unless otherwise stated. Thioflavin S practical sively restricted to BRAF and are present in approximate- grade (CAS 1326-12-1) was purchased from Sigma- ly 10% of all human tumors with the highest incidence of Aldrich. Calculation of molarity was based on informa- approximately 42% (Catalogue of Somatic Mutations in tion provided by the National Cancer Institute Develop- Cancer Database, Wellcome Sanger Trust) detected in mental Therapeutics Program (NCI-DTP; Rockville, MD; melanoma (1, 5, 18). Most commonly BRAF mutant mel- http://dtp.cancer.gov). Analytical grade reagents (n-hex- anoma are V600E (74%–90%; ref. 19) and 16% to 29% are ane, diethyl ether, ethyl acetate, n-butanol, petroleum V600K mutations (20, 21). Because of the role of RAF ether, acetone, dichloromethane, and methanol) were kinases in promoting cancer cell growth, mainly through supplied by VWR. High-performance liquid chromato- enforcing cell-cycle progression and enhancing cell sur- graphy (HPLC)-grade acetonitrile and methanol were vival (1, 5, 18, 22, 23), the RAS–RAF–MEK module has obtained from Merck. Deionized water (18.2 MO Â cm) become a promising target for therapeutic intervention. was obtained from an Arium 611 UV system (Sartorius This led to the development of small molecular weight Stedim Biotech GmbH). The MEK-inhibitor U0126 was inhibitors of RAF and MAP–ERK kinase (MEK; refs. 5, 24), purchased from Promega Corporation and prepared as a with recent clinical studies reporting that highly specific 10 mmol/L stock solution in dimethyl sulfoxide (DMSO; BRAF inhibitors are effective in the treatment of metastatic Sigma-Aldrich). AZD6244 (selumetinib) was obtained melanoma (25–27). However, initial promise has been from Eubio and prepared as a 10 mmol/L stock in DMSO. hampered by the development of resistance (28–30), Staurosporine (100 mmol/L stock) was obtained from which is characterized by the reactivation of ERK1/2 Sigma-Aldrich. RAF inhibitors sorafenib (BAY43-9006) (31–33) and has been attributed to various mechanisms and PLX4032 were obtained from Axon Medchem BV including activating NRAS mutations (29), CRAF over- and prepared as 50 mmol/L and 10 mmol/L stocks in expression (34), compensatory upregulation of MAP2K DMSO, respectively. Thioflavin S (Sigma-Aldrich) and kinase COT (28), activating MEK1 mutations (35), and purified compounds (Thio-2, Thio-3, and Thio-5; for iso- amplification of mutant BRAF (36). lation and purification see below) were prepared as a 10 Disruption of specific protein–protein interactions (PPI) mmol/L stock solution in DMSO. All inhibitors were within signalosomes may provide an alternative approach, finally diluted in culture medium
Recommended publications
  • The Apoptosis Database
    Cell Death and Differentiation (2003) 10, 621–633 & 2003 Nature Publishing Group All rights reserved 1350-9047/03 $25.00 www.nature.com/cdd Review The apoptosis database KS Doctor1, JC Reed1, A Godzik1 and PE Bourne*,1,2 Introduction 1 The Burnham Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037, The set of known proteins that directly regulate apoptosis has USA 2 San Diego Supercomputer Center, University of California San Diego, 9500 grown rapidly over the last 15 years. This growth will continue Gilman Drive, La Jolla, CA 92093-0505, USA until all the proteins directly involved in the cell death signaling * Corresponding author: PE Bourne, Tel: 858-534-8301; Fax: 858-822-0873, process are known. This assortment of proteins with wide E-mail: [email protected] ranging biochemical functions is linked together conceptually in the minds of apoptosis researchers. Assembling an up-to- Received 10.9.02; revised 3.12.02; accepted 10.12.02 date view of this conceptual collection of proteins within the Edited by Dr Green context of apoptosis requires a considerable effort, or more specifically, complete immersion into the field. One principal Abstract goal of an apoptosis review article is to assemble such a collection of protein annotations as an educational and The apoptosis database is a public resource for researchers research resource. The apoptosis database described here and students interested in the molecular biology of apoptosis. is designed to fulfil the same goal, but to immediately allow the The resource provides functional annotation, literature user to dig deeper using local and remote information and to references, diagrams/images, and alternative nomenclatures always remain current with respect to the proteins known to be on a set of proteins having ‘apoptotic domains’.
    [Show full text]
  • Bag6 Complex Contains a Minimal Tail-Anchor–Targeting Module and a Mock BAG Domain
    Bag6 complex contains a minimal tail-anchor–targeting module and a mock BAG domain Jee-Young Mocka, Justin William Chartrona,Ma’ayan Zaslavera,YueXub,YihongYeb, and William Melvon Clemons Jr.a,1 aDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA 91125; and bLaboratory of Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892 Edited by Gregory A. Petsko, Weill Cornell Medical College, New York, NY, and approved December 1, 2014 (received for review February 12, 2014) BCL2-associated athanogene cochaperone 6 (Bag6) plays a central analogous yeast complex contains two proteins, Get4 and Get5/ role in cellular homeostasis in a diverse array of processes and is Mdy2, which are homologs of the mammalian proteins TRC35 part of the heterotrimeric Bag6 complex, which also includes and Ubl4A, respectively. In yeast, these two proteins form ubiquitin-like 4A (Ubl4A) and transmembrane domain recognition a heterotetramer that regulates the handoff of the TA protein complex 35 (TRC35). This complex recently has been shown to be from the cochaperone small, glutamine-rich, tetratricopeptide important in the TRC pathway, the mislocalized protein degrada- repeat protein 2 (Sgt2) [small glutamine-rich tetratricopeptide tion pathway, and the endoplasmic reticulum-associated degrada- repeat-containing protein (SGTA) in mammals] to the delivery tion pathway. Here we define the architecture of the Bag6 factor Get3 (TRC40 in mammals) (19–22). It is expected that the complex, demonstrating that both TRC35 and Ubl4A have distinct mammalian homologs, along with Bag6, play a similar role (23– C-terminal binding sites on Bag6 defining a minimal Bag6 complex.
    [Show full text]
  • The HSP70 Chaperone Machinery: J Proteins As Drivers of Functional Specificity
    REVIEWS The HSP70 chaperone machinery: J proteins as drivers of functional specificity Harm H. Kampinga* and Elizabeth A. Craig‡ Abstract | Heat shock 70 kDa proteins (HSP70s) are ubiquitous molecular chaperones that function in a myriad of biological processes, modulating polypeptide folding, degradation and translocation across membranes, and protein–protein interactions. This multitude of roles is not easily reconciled with the universality of the activity of HSP70s in ATP-dependent client protein-binding and release cycles. Much of the functional diversity of the HSP70s is driven by a diverse class of cofactors: J proteins. Often, multiple J proteins function with a single HSP70. Some target HSP70 activity to clients at precise locations in cells and others bind client proteins directly, thereby delivering specific clients to HSP70 and directly determining their fate. In their native cellular environment, polypeptides are participates in such diverse cellular functions. Their constantly at risk of attaining conformations that pre- functional diversity is remarkable considering that vent them from functioning properly and/or cause them within and across species, HSP70s have high sequence to aggregate into large, potentially cytotoxic complexes. identity. They share a single biochemical activity: an Molecular chaperones guide the conformation of proteins ATP-dependent client-binding and release cycle com- throughout their lifetime, preventing their aggregation bined with client protein recognition, which is typi- by protecting interactive surfaces against non-productive cally rather promiscuous. This apparent conundrum interactions. Through such inter actions, molecular chap- is resolved by the fact that HSP70s do not work alone, erones aid in the folding of nascent proteins as they are but rather as ‘HSP70 machines’, collaborating with synthesized by ribosomes, drive protein transport across and being regulated by several cofactors.
    [Show full text]
  • LOXL1 Confers Antiapoptosis and Promotes Gliomagenesis Through Stabilizing BAG2
    Cell Death & Differentiation (2020) 27:3021–3036 https://doi.org/10.1038/s41418-020-0558-4 ARTICLE LOXL1 confers antiapoptosis and promotes gliomagenesis through stabilizing BAG2 1,2 3 4 3 4 3 1 1 Hua Yu ● Jun Ding ● Hongwen Zhu ● Yao Jing ● Hu Zhou ● Hengli Tian ● Ke Tang ● Gang Wang ● Xiongjun Wang1,2 Received: 10 January 2020 / Revised: 30 April 2020 / Accepted: 5 May 2020 / Published online: 18 May 2020 © The Author(s) 2020. This article is published with open access Abstract The lysyl oxidase (LOX) family is closely related to the progression of glioma. To ensure the clinical significance of LOX family in glioma, The Cancer Genome Atlas (TCGA) database was mined and the analysis indicated that higher LOXL1 expression was correlated with more malignant glioma progression. The functions of LOXL1 in promoting glioma cell survival and inhibiting apoptosis were studied by gain- and loss-of-function experiments in cells and animals. LOXL1 was found to exhibit antiapoptotic activity by interacting with multiple antiapoptosis modulators, especially BAG family molecular chaperone regulator 2 (BAG2). LOXL1-D515 interacted with BAG2-K186 through a hydrogen bond, and its lysyl 1234567890();,: 1234567890();,: oxidase activity prevented BAG2 degradation by competing with K186 ubiquitylation. Then, we discovered that LOXL1 expression was specifically upregulated through the VEGFR-Src-CEBPA axis. Clinically, the patients with higher LOXL1 levels in their blood had much more abundant BAG2 protein levels in glioma tissues. Conclusively, LOXL1 functions as an important mediator that increases the antiapoptotic capacity of tumor cells, and approaches targeting LOXL1 represent a potential strategy for treating glioma.
    [Show full text]
  • The Interplay Between Bag-1, Hsp70, and Hsp90 Reveals That Inhibiting Hsp70 Rebinding Is Essential for Glucocorticoid Receptor Activity
    bioRxiv preprint doi: https://doi.org/10.1101/2020.05.03.075523; this version posted May 5, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. The interplay between Bag-1, Hsp70, and Hsp90 reveals that inhibiting Hsp70 rebinding is essential for Glucocorticoid Receptor activity Authors: Elaine Kirschke, Zygy Roe-Zurz, Chari Noddings, and David Agard Affiliations: Department of Biochemistry and Biophysics, University of California, San Francisco, CA 94158, USA Keywords: Glucocorticoid Receptor, Hsp90, Hsp70, Bag-1, nucleotide exchange factor Author contributions: Z.R.Z. carried out Hsp70 nucleotide dissociation experiments. E.K. carried out GRLBD ligand binding experiments and assembled all the data. E.K. and D.A.A. wrote the manuscript. Abstract The glucocorticoid receptor (GR), like many signaling proteins requires Hsp90 for sustained activity. Previous biochemical studies revealed that the requirement for Hsp90 is explained by its ability to reverse Hsp70-mediated inactivation of GR through a complex process requiring both cochaperones and Hsp90 ATP hydrolysis. How ATP hydrolysis on Hsp90 enables GR reactivation is unknown. The canonical mechanism of client release from Hsp70 requires ADP:ATP exchange, which is normally rate limiting. Here we show that independent of ATP hydrolysis, Hsp90 acts as an Hsp70 nucleotide exchange factor (NEF) to accelerate ADP dissociation, likely coordinating GR transfer from Hsp70 to Hsp90. As Bag-1 is a canonical Hsp70 NEF that can also reactivate Hsp70:GR, the impact of these two NEFs was compared. Simple acceleration of Hsp70:GR release was insufficient for GR reactivation as Hsp70 rapidly re-binds and re-inactivates GR.
    [Show full text]
  • Associated Athanogene (BAG) Protein Family in Rice
    African Journal of Biotechnology Vol. 11(1), pp. 88-99, 3 January, 2012 Available online at http://www.academicjournals.org/AJB DOI: 10.5897/AJB11.3474 ISSN 1684–5315 © 2012 Academic Journals Full Length Research Paper Identification and characterization of the Bcl-2- associated athanogene (BAG) protein family in rice Rashid Mehmood Rana 1, 2 , Shinan Dong 1, Zulfiqar Ali 3, Azeem Iqbal Khan 4 and Hong Sheng Zhang 1* 1State Key Laboratory of Crop Genetics and Germplasm Enhancement, Nanjing Agricultural University, Nanjing 210095, China. 2Department of Plant Breeding and Genetics, PMAS-Arid Agriculture University Rawalpindi, Pakistan. 3Department of Plant Breeding and Genetics, University of Agriculture, Faisalabad-38040, Pakistan. 4Centre of Agricultural Biochemistry and Biotechnology (CABB), University of Agriculture, Faisalabad-38040, Pakistan. Accepted 9 December, 2011 The Bcl-2-associated athanogene (BAG) proteins are involved in the regulation of Hsp70/HSC70 in animals. There are six BAG genes in human that encode nine isoforms with different subcellular locations. Arabidopsis thaliana is reported to contain seven BAG proteins. We searched BAG proteins in Oryza sativa using profile-sequence (Pfam) and profile-profile (FFAS) algorithms and found six homologs. The BAG protein family in O. sativa can be grouped into two classes based on the presence of other conserved domains. Class I consists of four OsBAG genes (1 to 4) containing an additional ubiquitin-like domain, structurally similar to the human BAG1 proteins and might be BAG1 orthologs in plants. Class II consists of two OsBAG genes (5 and 6) containing calmodulin-binding domain. Multiple sequence alignment and structural models of O.
    [Show full text]
  • Bag-1 Stimulates Bad Phosphorylation Through Activation of Akt and Raf Kinases to Mediate Cell Survival in Breast Cancer
    Kizilboga et al. BMC Cancer (2019) 19:1254 https://doi.org/10.1186/s12885-019-6477-4 RESEARCH ARTICLE Open Access Bag-1 stimulates Bad phosphorylation through activation of Akt and Raf kinases to mediate cell survival in breast cancer Tugba Kizilboga1, Emine Arzu Baskale1, Jale Yildiz1, Izzet Mehmet Akcay1, Ebru Zemheri2, Nisan Denizce Can1, Can Ozden1, Salih Demir1, Fikret Ezberci3 and Gizem Dinler-Doganay1* Abstract Background: Bag-1 (Bcl-2-associated athanogene) is a multifunctional anti-apoptotic protein frequently overexpressed in cancer. Bag-1 interacts with a variety of cellular targets including Hsp70/Hsc70 chaperones, Bcl-2, nuclear hormone receptors, Akt and Raf kinases. In this study, we investigated in detail the effects of Bag-1 on major cell survival pathways associated with breast cancer. Methods: Using immunoblot analysis, we examined Bag-1 expression profiles in tumor and normal tissues of breast cancer patients with different receptor status. We investigated the effects of Bag-1 on cell proliferation, apoptosis, Akt and Raf kinase pathways, and Bad phosphorylation by implementing ectopic expression or knockdown of Bag-1 in MCF-7, BT-474, MDA-MB-231 and MCF-10A breast cell lines. We also tested these in tumor and normal tissues from breast cancer patients. We investigated the interactions between Bag-1, Akt and Raf kinases in cell lines and tumor tissues by co-immunoprecipitation, and their subcellular localization by immunocytochemistry and immunohistochemistry. Results: We observed that Bag-1 is overexpressed in breast tumors in all molecular subtypes, i.e., regardless of their ER, PR and Her2 expression profile. Ectopic expression of Bag-1 in breast cancer cell lines results in the activation of B-Raf, C-Raf and Akt kinases, which are also upregulated in breast tumors.
    [Show full text]
  • Origin and Evolution of the Human Bcl2-Associated Athanogene-1 (BAG-1)
    International Journal of Molecular Sciences Article Origin and Evolution of the Human Bcl2-Associated Athanogene-1 (BAG-1) 1, 2, 1 1 1 Peter Nguyen y, Kyle Hess y , Larissa Smulders , Dat Le , Carolina Briseno , Christina M. Chavez 1 and Nikolas Nikolaidis 1,* 1 Center for Applied Biotechnology Studies, and Center for Computational and Applied Mathematics, Department of Biological Science, College of Natural Sciences and Mathematics, California State University Fullerton, Fullerton, CA 92834-6850, USA; [email protected] (P.N.); [email protected] (L.S.); [email protected] (D.L.); [email protected] (C.B.); [email protected] (C.M.C.) 2 Department of Genome Sciences, Molecular and Cellular Biology Graduate Program, University of Washington, Seattle, WA 98195, USA; [email protected] * Correspondence: [email protected]; Tel.: +1-657-278-4526 These authors contributed equally to this work. y Received: 20 November 2020; Accepted: 17 December 2020; Published: 18 December 2020 Abstract: Molecular chaperones, particularly the 70-kDa heat shock proteins (Hsp70s), are key orchestrators of the cellular stress response. To perform their critical functions, Hsp70s require the presence of specific co-chaperones, which include nucleotide exchange factors containing the BCL2-associated athanogene (BAG) domain. BAG-1 is one of these proteins that function in a wide range of cellular processes, including apoptosis, protein refolding, and degradation, as well as tumorigenesis. However, the origin of BAG-1 proteins and their evolution between and within species are mostly uncharacterized. This report investigated the macro- and micro-evolution of BAG-1 using orthologous sequences and single nucleotide polymorphisms (SNPs) to elucidate the evolution and understand how natural variation affects the cellular stress response.
    [Show full text]
  • UNIVERSITY of CALIFORNIA SAN DIEGO P209L Mutation in BAG3
    UNIVERSITY OF CALIFORNIA SAN DIEGO P209L Mutation in BAG3 Does Not Cause Cardiomyopathy in Mice A Thesis submitted in partial satisfaction of the requirements for the degree Master of Science in Biology by Paul Zhou Committee in charge: Ju Chen, Chair Michael David, Co-Chair Jon Christopher Armour 2018 The Thesis of Paul Zhou is approved, and it is acceptable in quality and form for publication on microfilm and electronically: Co-Chair Chair University of California San Diego 2018 iii DEDICATION I dedicate this thesis to my incredible parents, who gave meaning to my life. Without their immense sacrifice and unconditional love, I would never be able to achieve my dream. iv TABLE OF CONTENTS Signature page ..................................................................................................................................... iii Dedication ............................................................................................................................................. iv Table of Contents.................................................................................................................................. v List of Abbreviations ......................................................................................................................... vi List of Figures ..................................................................................................................................... vii Acknowledgements ...........................................................................................................................
    [Show full text]
  • The BAG Homology Domain of Snl1 Cures Yeast Prion [URE3] Through Regulation of Hsp70 Chaperones
    INVESTIGATION The BAG Homology Domain of Snl1 Cures Yeast Prion [URE3] Through Regulation of Hsp70 Chaperones Navinder Kumar,* Deepika Gaur,* Daniel C. Masison,† and Deepak Sharma*,1 *Council of Scientific and Industrial Research-Institute of Microbial Technology, Chandigarh, India, and †Laboratory of Biochemistry and Genetics, National Institutes of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland ABSTRACT The BAG family of proteins is evolutionarily conserved from yeast to humans and plants. In KEYWORDS animals and plants, the BAG family possesses multiple members with overlapping and distinct functions that Hsp70 regulate many cellular processes, such as signaling, protein degradation, and stress response. The only nucleotide BAG domain protein in Saccharomyces cerevisiae is Snl1, which is anchored to the endoplasmic reticulum exchange factor through an amino-terminal transmembrane region. Snl1 is the only known membrane-associated nucleotide yeast prion exchange factor for 70-kilodalton heat shock protein (Hsp70), and thus its role in regulating cytosolic Hsp70 Snl1 functions is not clear. Here, we examine whether Snl1 regulates Hsp70 activity in the propagation of stable BAG domain prion-like protein aggregates. We show that unlike other nucleotide exchange factors, Snl1 is not required for propagation of yeast prions [URE3] and [PSI+]. Overexpressing Snl1 derivative consisting of only the BAG domain (Snl1-S) cures [URE3]; however, elevated levels of the entire cytosolic domain of Snl1 (Snl1-M), which has nine additional amino-terminal residues, has no effect. Substituting the three lysine residues in this region of Snl1-M with alanine restores ability to cure [URE3]. [PSI+] is unaffected by overproduction of either Snl1-S or Snl1-M.
    [Show full text]
  • Hsp70–Bag3 Complex Is a Hub for Proteotoxicity-Induced Signaling
    Hsp70–Bag3 complex is a hub for proteotoxicity- induced signaling that controls protein aggregation Anatoli B. Meriina, Arjun Narayananb, Le Menga, Ilya Alexandrovc, Xaralabos Varelasa, Ibrahim I. Cisséb, and Michael Y. Shermand,1 aDepartment of Biochemistry, Boston University School of Medicine, Boston, MA 02118; bDepartment of Physics, Massachusetts Institute of Technology, Cambridge, MA 02139; cActivSignal, Watertown, MA 02471; and dDepartment of Molecular Biology, Ariel University, Ariel 40700, Israel Edited by Alfred Lewis Goldberg, Harvard Medical School, Boston, MA, and approved June 13, 2018 (received for review March 21, 2018) Protein abnormalities in cells are the cause of major pathologies, Bag3 suggests that it can serve as a scaffold that links Hsp70 with and a number of adaptive responses have evolved to relieve the multiple signaling pathways. toxicity of misfolded polypeptides. To trigger these responses, Considering that the HB complex has the capacity to interact with cells must detect the buildup of aberrant proteins which often abnormal protein molecules (9, 10), we hypothesized that this associate with proteasome failure, but the sensing mechanism is module could act as a sensor of protein abnormalities in the cell and poorly understood. Here we demonstrate that this mechanism transduce signals to downstream pathways. Here we describe three involves the heat shock protein 70–Bcl-2–associated athanogene 3 pathways (i.e., JNK, p38, and Lats1/2) which are regulated under – (Hsp70 Bag3) complex, which upon proteasome suppression re- proteotoxic conditions via interactions with the HB complex. We sponds to the accumulation of defective ribosomal products, pref- found that upon proteasome failure this complex primarily senses erentially recognizing the stalled polypeptides.
    [Show full text]
  • Cooperation of a Ubiquitin Domain Protein and an E3 Ubiquitin Ligase
    Research Paper 1569 Cooperation of a ubiquitin domain protein and an E3 ubiquitin ligase during chaperone/proteasome coupling Jens Demand*§, Simon Alberti‡, Cam Patterson† and Jo¨ rg Ho¨ hfeld‡ Background: Molecular chaperones recognize nonnative proteins and Addresses: *Abteilung fu¨r Molekulare Zellbiologie, orchestrate cellular folding processes in conjunction with regulatory Max-Planck-Institut fu¨r Biochemie, D-82152 † cofactors. However, not every attempt to fold a protein is successful, and Martinsried, Germany. Program in Molecular Cardiology and Lineberger Comprehensive misfolded proteins can be directed to the cellular degradation machinery Cancer Center, University of North Carolina, for destruction. Molecular mechanisms underlying the cooperation of Chapel Hill, North Carolina 27599, USA. ‡Institut molecular chaperones with the degradation machinery remain largely fu¨r Zellbiologie, Rheinische-Friedrich-Wilhelms- enigmatic so far. Universita¨t Bonn, Ulrich-Haberland-Str. 61a, D-53121 Bonn, Germany. Results: By characterizing the chaperone cofactors BAG-1 and CHIP, we Present address: §MediGene AG, D-82152 gained insight into the cooperation of the molecular chaperones Hsc70 Martinsried, Germany. and Hsp70 with the ubiquitin/proteasome system, a major system for protein degradation in eukaryotic cells. The cofactor CHIP acts as a ubiquitin Correspondence: Dr. Jo¨ rg Ho¨ hfeld ligase in the ubiquitination of chaperone substrates such as the raf-1 protein E-mail: [email protected] kinase and the glucocorticoid hormone receptor. During targeting of signaling molecules to the proteasome, CHIP may cooperate with BAG-1, Received: 26 July 2001 21 August 2001 a ubiquitin domain protein previously shown to act as a coupling factor between Revised: Accepted: 4 September 2001 Hsc/Hsp70 and the proteasome.
    [Show full text]